camptothecin has been researched along with entinostat in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hetman, M; Vashishta, A | 1 |
| Baylin, SB; Dobromilskaya, I; Easwaran, H; Huang, P; Poirier, JT; Rudin, CM; Topper, M; Vendetti, FP; Wrangle, J | 1 |
2 other study(ies) available for camptothecin and entinostat
| Article | Year |
|---|---|
Inhibitors of histone deacetylases enhance neurotoxicity of DNA damage.
Topics: Animals; Animals, Newborn; Antineoplastic Agents; Apoptosis; Benzamides; Camptothecin; Cells, Cultured; Cerebral Cortex; Cisplatin; Dizocilpine Maleate; DNA Breaks, Double-Stranded; Etoposide; Genes, p53; Histone Deacetylase 1; Histone Deacetylase Inhibitors; Hydroxamic Acids; Injections, Intraventricular; Neurons; Phosphorylation; Point Mutation; Protein Processing, Post-Translational; Pyridines; Rats; Rats, Sprague-Dawley; Tumor Suppressor Protein p53; Vorinostat | 2014 |
Evaluation of azacitidine and entinostat as sensitization agents to cytotoxic chemotherapy in preclinical models of non-small cell lung cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Benzamides; Camptothecin; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; DNA Methylation; Drug Evaluation, Preclinical; Epigenesis, Genetic; Female; Histones; Humans; Irinotecan; Lung Neoplasms; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Transplantation; Pyridines | 2015 |